These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism. Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298 [TBL] [Abstract][Full Text] [Related]
3. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567 [TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases. Médeau V; Moreau F; Trinquart L; Clemessy M; Wémeau JL; Vantyghem MC; Plouin PF; Reznik Y Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637 [TBL] [Abstract][Full Text] [Related]
5. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. Letavernier E; Peyrard S; Amar L; Zinzindohoué F; Fiquet B; Plouin PF J Hypertens; 2008 Sep; 26(9):1816-23. PubMed ID: 18698217 [TBL] [Abstract][Full Text] [Related]
6. Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Rossi H; Kim A; Prinz RA Am Surg; 2002 Mar; 68(3):253-6; discussion 256-7. PubMed ID: 11893103 [TBL] [Abstract][Full Text] [Related]
7. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]. Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287 [TBL] [Abstract][Full Text] [Related]
8. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956 [TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and surgery outcomes of unilateral nodular adrenal hyperplasia in primary aldosteronism: study of 145 cases]. Wu JC; Tang ZY; Zhang W; Ling DY; Hou RF; Wang WQ; Li XY; Ning G Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3302-5. PubMed ID: 17313818 [TBL] [Abstract][Full Text] [Related]
11. Primary aldosteronism. A follow-up study of 28 cases of surgically treated aldosterone-producing adenomas. Lins PE; Adamson U Acta Med Scand; 1987; 221(3):275-82. PubMed ID: 3296673 [TBL] [Abstract][Full Text] [Related]
12. Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. Rossi GP; Chiesura-Corona M; Tregnaghi A; Zanin L; Perale R; Soattin S; Pelizzo MR; Feltrin GP; Pessina AC J Hum Hypertens; 1993 Aug; 7(4):357-63. PubMed ID: 8410926 [TBL] [Abstract][Full Text] [Related]
13. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318 [TBL] [Abstract][Full Text] [Related]
14. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism. Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890 [TBL] [Abstract][Full Text] [Related]
15. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Hood SJ; Taylor KP; Ashby MJ; Brown MJ Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839 [TBL] [Abstract][Full Text] [Related]
16. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003 [TBL] [Abstract][Full Text] [Related]
17. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma. Biglieri EG; Kater CE; Arteaga EE J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673 [TBL] [Abstract][Full Text] [Related]
18. Laparoscopic adrenal-sparing surgery for primary hyperaldosteronism due to aldosterone-producing adenoma. Kok KY; Yapp SK Surg Endosc; 2002 Jan; 16(1):108-11. PubMed ID: 11961617 [TBL] [Abstract][Full Text] [Related]
19. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I. Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619 [TBL] [Abstract][Full Text] [Related]